ArticleHeadache

Swiss Quality of Life and Health Care Impact Assessment in a Real-World Erenumab-Treated Migraine Population: Results over 2 years.

Andreas R Gantenbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.